Navigation Links
Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology

Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, announced the acquisition of a novel anti-rejection technology for use in organ transplantation.

Circassia acquired the proprietary technology, known as ToleroTrans, from The University of Birmingham in the UK for an undisclosed upfront sum, plus future milestone payments and royalties on product sales. Scientifically, the ToleroTrans approach mirrors that of Circassia's existing anti-allergy technology, by utilising T-cell epitopes to down-regulate patients' unwanted immune responses.

"The acquisition of the ToleroTrans anti-rejection technology provides us with a unique opportunity to expand our pipeline of next generation immune control medicines," said Steve Harris, Circassia's CEO. "Our current anti-allergy technology works via a very similar mechanism, meaning ToleroTrans fits perfectly within our scientific focus. I am delighted that we have completed this acquisition so soon after establishing Circassia earlier this year, and believe it will prove an important step in building a broad, world-class immune control company."

Organ transplantation is a complex medical undertaking, which requires careful tissue type matching between the donor and recipient to reduce the risk of rejection. Organ rejection can occur when the recipient's immune system reacts strongly to protein molecules, termed antigens, present on the cells of the donated organ. The ToleroTrans technology employs specific small portions of antigen molecules, called T-cell epitopes. Scientists then test these epitopes, utilising blood samples from patients awaiting organ transplantation, to determine which have the potential to desensitize the recipient's immune system, and thereby reduce the risk of rejection.


'"/>




Page: 1

Related medicine news :

1. Ramdoss Announces Introduction of RCH-II
2. Britain Announces Third Transfusion Related Mad Cow Case
3. Tibet Announces the Dalai Lama’s Tour of South Americ
4. Indian PM Announces Of Setting Up India Study Center At Tashkent
5. PowderMed Announces Needle-Less Flu Vaccine
6. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Australian Government Announces Survey To Tackle Childhood Obesity
9. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
10. Apollo Announces Research on Indian Cardiac Epidemic
11. Government Announces Steps To Promote Ayurvedic Medicine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, ... announced today that a new solution for Emergency Departments (ED) has been added ... space in Emergency Department examination rooms, and with a simplified pallet of information ...
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The report forecasts the global optical transceiver ... 2016-2020. The report covers the present scenario and ... To calculate the market size, the report considers the revenue generated ...
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
Breaking Medicine Technology: